Hematological Findings in COVID-19 and Insights to Stem Cell Therapy: From Bench to Practice

Context: As the COVID-19 was spreading to all countries, its manifestations were identifying gradually, which related several organs. Evidence Acquisition: is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. Most of these changes are patients’ prognosis mortality, particularly in those severe disease. Results: Firstly, we discussed associations between clinical features complications, secondly, findings coagulopathy investigated. Conclusions: Such not only may shed light on our prognostic view patients but also will entail significant therapeutic implications. One key implications utilize mesenchymal stem cells (MSCs) treat COVID-19. Herein, this kind novel therapy be discussed, as well.